发明名称 Pharmaceutical coposition
摘要 <p>A composition comprising a compound of formula (I) wherein R represents a halogen atom or a C 1-4 alkyl group; R 1 represents a C 1-4 alkyl group; R 2 represents hydrogen or a C 1-4 alkyl group; R 3 represents hydrogen, or a C 1-4 alkyl group; R 4 represents a trifluoromethyl group; R 5 represents hydrogen, a C 1-4 alkyl group or C(O)R 6 ; R 6 represents C 1-4 alkyl, C 3-7 cycloalkyl, NH(C 1-4 alkyl) or N(C1-4alkyl) 2 ; m is zero or an integer from 1 to 3; n is an integer from 1 to 3 or pharmaceutically acceptable salts or solvates thereof and a selective serotonin reuptake inhibitor.</p>
申请公布号 EP1752449(A1) 申请公布日期 2007.02.14
申请号 EP20060122021 申请日期 2001.10.12
申请人 GLAXO GROUP LIMITED 发明人 ALVARO, GIUSEPPE;DI FABIO, ROMANO;MARAGNI, PAOLO;TAMPIERI, MARISA;TRANQUILLINI, MARIA ELVIRA
分类号 C07D211/58;A61K31/445;A61K31/496;A61P25/00;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/36 主分类号 C07D211/58
代理机构 代理人
主权项
地址